| 1 |
35563117 | Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. | 2022 Apr 25 |
2 |
| 2 |
34332233 | Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation. | 2021 Oct |
1 |
| 3 |
33107777 | Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy. | 2020 Dec |
1 |
| 4 |
29621036 | Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease. | 2018 Jul |
1 |
| 5 |
27618583 | C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation. | 2017 Apr |
1 |
| 6 |
21060209 | Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets. | 2011 |
1 |
| 7 |
19782138 | Ligand-enhanced expression and in-cell assay of human peroxisome proliferator-activated receptor alpha ligand binding domain. | 2010 Apr |
2 |
| 8 |
19929038 | Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia. | 2009 |
1 |
| 9 |
17533223 | Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. | 2007 Aug |
2 |
| 10 |
17022944 | Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. | 2006 Nov 24 |
3 |
| 11 |
15685545 | Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. | 2005 Feb |
2 |
| 12 |
14982965 | A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice. | 2004 Jun |
1 |
| 13 |
15169608 | Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages. | 2004 May |
2 |
| 14 |
14613528 | Induction of Tissue Factor Expression in Endothelial Cells by Basic Fibroblast Growth Factor and its Modulation by Fenofibric acid. | 2003 Oct 11 |
1 |
| 15 |
12006402 | Induction of plasminogen activator inhibitor-1 in endothelial cells by basic fibroblast growth factor and its modulation by fibric acid. | 2002 May 1 |
1 |
| 16 |
14727988 | Micronized fenofibrate in dyslipidemia: a focus on plasma high-density lipoprotein cholesterol (HDL-C) levels. | 2002 |
1 |